From cardiovascular disease to Alzheimer’s, the retina is proving to be the body’s most revealing health monitor, positioning optometrists at the forefront of early detection and integrated care.
Ascertain — a healthcare AI company creation platform formed last year by Northwell Health and Aegis Ventures — has launched its first startup. New York-based Optain, which has gained an initial seed investment of $12 million, is an AI company meant to enable earlier disease detection and prevention through retinal imaging.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
If the eyes are the window to the soul, Google thinks it's proven that images of the retina can offer a window on the state of the heart.